Literature DB >> 1590990

Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction.

A S Rosenberg1, A Singer.   

Abstract

Rejection of transplanted tissue allografts results from T-cell recognition of histocompatibility antigens expressed by cells of the donor graft. This review focuses on the phenotype, specificity, and function of the T cells mediating rejection responses against skin allografts, and on the immune mechanisms by which host T cells are either activated or rendered non-responsive by cellular populations within the graft. We review the cellular basis for rejection responses across limited class-I and class-II major histocompatibility differences, as well as the specificity of the rejection response itself.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590990     DOI: 10.1146/annurev.iy.10.040192.002001

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  59 in total

Review 1.  Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation.

Authors:  A L Bothwell
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma.

Authors:  Masayoshi Miura; Tarek El-Sawy; Robert L Fairchild
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

4.  Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.

Authors:  Tarek El-Sawy; Masayoshi Miura; Robert Fairchild
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 5.  Progress on new vaccine strategies for the immunotherapy and prevention of cancer.

Authors:  Jay A Berzofsky; Masaki Terabe; SangKon Oh; Igor M Belyakov; Jeffrey D Ahlers; John E Janik; John C Morris
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 6.  Routes to transplant tolerance versus rejection; the role of cytokines.

Authors:  Patrick T Walsh; Terry B Strom; Laurence A Turka
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

7.  Langerhans cells are not required for efficient skin graft rejection.

Authors:  Jagdeep S Obhrai; Martin Oberbarnscheidt; Na Zhang; Daniel L Mueller; Warren D Shlomchik; Fadi G Lakkis; Mark J Shlomchik; Daniel H Kaplan
Journal:  J Invest Dermatol       Date:  2008-03-13       Impact factor: 8.551

8.  A critical precursor frequency of donor-reactive CD4+ T cell help is required for CD8+ T cell-mediated CD28/CD154-independent rejection.

Authors:  Mandy L Ford; Maylene E Wagener; Samantha S Hanna; Thomas C Pearson; Allan D Kirk; Christian P Larsen
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation.

Authors:  K L Rokahr; A F Sharland; J Sun; C Wang; A G Sheil; Y Yan; G W McCaughan; G A Bishop
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

10.  Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.

Authors:  A G Murray; J S Schechner; D E Epperson; P Sultan; J M McNiff; C C Hughes; M I Lorber; P W Askenase; J S Pober
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.